骨肉瘤的基因免疫治疗:从溶瘤载体到工程化免疫细胞
Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells.
77.2分
★★★★☆
站内排序·非疗效
ALL SOURCES
Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells.
Reprogramming adoptive cell therapy for osteosarcoma: engineering, vaccination, and tumor microenvironment remodeling.
Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcoma.
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
该研究为 EphA2 靶向 CAR-NK 细胞治疗在一系列儿童肉瘤中的临床评价提供了基础依据。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。